Matches in Wikidata for { <http://www.wikidata.org/entity/Q95826229> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- Q95826229 description "article scientifique publié en 2018" @default.
- Q95826229 description "wetenschappelijk artikel" @default.
- Q95826229 description "наукова стаття" @default.
- Q95826229 name "Real-life Anti-tumor Necrosis Factor Experience in More Than 500 Patients: High Co-immunosuppression Rates But Low Rates of Quantifying Treatment Response" @default.
- Q95826229 name "Real-life Anti-tumor Necrosis Factor Experience in More Than 500 Patients: High Co-immunosuppression Rates But Low Rates of Quantifying Treatment Response" @default.
- Q95826229 type Item @default.
- Q95826229 label "Real-life Anti-tumor Necrosis Factor Experience in More Than 500 Patients: High Co-immunosuppression Rates But Low Rates of Quantifying Treatment Response" @default.
- Q95826229 label "Real-life Anti-tumor Necrosis Factor Experience in More Than 500 Patients: High Co-immunosuppression Rates But Low Rates of Quantifying Treatment Response" @default.
- Q95826229 prefLabel "Real-life Anti-tumor Necrosis Factor Experience in More Than 500 Patients: High Co-immunosuppression Rates But Low Rates of Quantifying Treatment Response" @default.
- Q95826229 prefLabel "Real-life Anti-tumor Necrosis Factor Experience in More Than 500 Patients: High Co-immunosuppression Rates But Low Rates of Quantifying Treatment Response" @default.
- Q95826229 P1433 Q95826229-3BABF254-AA4E-41A0-8FC1-A4C2C79283DA @default.
- Q95826229 P1476 Q95826229-5886CAD4-FAAE-4B63-B800-1AB608FD3867 @default.
- Q95826229 P2093 Q95826229-00D77B7C-F00E-4F05-8E86-4280CD32E075 @default.
- Q95826229 P2093 Q95826229-060BFAE3-EFB4-4ACA-852A-DC5731D24C7B @default.
- Q95826229 P2093 Q95826229-09AD85E9-8961-41BB-9606-F1F5EBC97977 @default.
- Q95826229 P2093 Q95826229-254B7E34-E3C2-4FC7-A824-5211CF2576FC @default.
- Q95826229 P2093 Q95826229-2F47D531-5FE7-407F-A2A9-8C8C73B789DC @default.
- Q95826229 P2093 Q95826229-324C884B-ED7C-47BB-BB85-51FD8D2DBF8E @default.
- Q95826229 P2093 Q95826229-36E3711F-2AB1-4225-99C8-D72749E19134 @default.
- Q95826229 P2093 Q95826229-3B9F8E3B-B700-491C-AFCE-1C1D4A741275 @default.
- Q95826229 P2093 Q95826229-4C311F49-217B-4AFD-B078-E89AE060D1C5 @default.
- Q95826229 P2093 Q95826229-6A3ACDC4-F798-461A-8B68-B6520C5207A5 @default.
- Q95826229 P2093 Q95826229-784F907F-1139-4C12-99A3-0CFB759E1FE0 @default.
- Q95826229 P2093 Q95826229-79399A98-A398-403D-8A53-9623D97BBED7 @default.
- Q95826229 P2093 Q95826229-91925BE1-5667-4598-93B6-B42735354B39 @default.
- Q95826229 P2093 Q95826229-9BA6EF05-CCD5-457E-81AF-4C67B13EC5B0 @default.
- Q95826229 P2093 Q95826229-A395802D-F368-4AE9-B2F9-011B3A9028BF @default.
- Q95826229 P2093 Q95826229-A85C4A7C-B67C-488C-905C-1B114DBA1442 @default.
- Q95826229 P2093 Q95826229-B94E62B0-059C-410F-895D-2277FD905E1E @default.
- Q95826229 P2093 Q95826229-E7BD97D1-BAFD-447B-87AF-CA2444524F24 @default.
- Q95826229 P2093 Q95826229-E905B7C2-CD50-418F-B2FC-DC98584A5C91 @default.
- Q95826229 P2093 Q95826229-E9A00755-9034-431A-8CF5-51528076A49F @default.
- Q95826229 P2093 Q95826229-EAE43E10-7875-4882-974B-30828B1342FD @default.
- Q95826229 P2093 Q95826229-F0BC7296-CDA7-4302-AB14-29B7E6869537 @default.
- Q95826229 P2093 Q95826229-F14C3BDF-8ABF-4A84-8AF8-3E71FBC127BF @default.
- Q95826229 P304 Q95826229-05846F7F-A7B1-45D1-98BA-2F8F7F6D8123 @default.
- Q95826229 P31 Q95826229-515F6F6C-49A6-4407-9C7C-D222896E0D8E @default.
- Q95826229 P356 Q95826229-2521859F-70BD-4746-B373-76C4F6398ECF @default.
- Q95826229 P433 Q95826229-49A57B8F-FD65-4D34-BD7C-26A417902E49 @default.
- Q95826229 P478 Q95826229-3DF6BDE9-0552-4482-8716-3012A03EE3FC @default.
- Q95826229 P50 Q95826229-8C9241D2-6C6D-4FE7-940B-17F0F5D6BC11 @default.
- Q95826229 P577 Q95826229-E7885685-72EE-4575-B568-F6D9F0693830 @default.
- Q95826229 P698 Q95826229-F6066E99-831B-43DE-ABEA-25B228A5FD4B @default.
- Q95826229 P356 MPG.0000000000001679 @default.
- Q95826229 P698 29356768 @default.
- Q95826229 P1433 Q6295721 @default.
- Q95826229 P1476 "Real-life Anti-tumor Necrosis Factor Experience in More Than 500 Patients: High Co-immunosuppression Rates But Low Rates of Quantifying Treatment Response" @default.
- Q95826229 P2093 "Anthony Akobeng" @default.
- Q95826229 P2093 "Astor Rodrigues" @default.
- Q95826229 P2093 "Babu Vadamalayan" @default.
- Q95826229 P2093 "Charles Charlton" @default.
- Q95826229 P2093 "David C Wilson" @default.
- Q95826229 P2093 "Franco Torrente" @default.
- Q95826229 P2093 "Huw Jenkins" @default.
- Q95826229 P2093 "John M E Fell" @default.
- Q95826229 P2093 "Kajal Mortier" @default.
- Q95826229 P2093 "Linda J Williams" @default.
- Q95826229 P2093 "Mamoun Elawad" @default.
- Q95826229 P2093 "Marcus K H Auth" @default.
- Q95826229 P2093 "Mark Furman" @default.
- Q95826229 P2093 "Mary-Anne Morris" @default.
- Q95826229 P2093 "Mike Cosgrove" @default.
- Q95826229 P2093 "Nick M Croft" @default.
- Q95826229 P2093 "Rafeeq Muhammed" @default.
- Q95826229 P2093 "Richard K Russell" @default.
- Q95826229 P2093 "Sabarinathan Loganathan" @default.
- Q95826229 P2093 "Sally G Mitton" @default.
- Q95826229 P2093 "Sonny Chong" @default.
- Q95826229 P2093 "Veena Zamvar" @default.
- Q95826229 P2093 "Victoria M Merrick" @default.
- Q95826229 P304 "274-280" @default.
- Q95826229 P31 Q13442814 @default.
- Q95826229 P356 "10.1097/MPG.0000000000001679" @default.
- Q95826229 P433 "2" @default.
- Q95826229 P478 "66" @default.
- Q95826229 P50 Q70677805 @default.
- Q95826229 P577 "2018-02-01T00:00:00Z" @default.
- Q95826229 P698 "29356768" @default.